GSK announces start of Phase lll programme for mepolizumab in severe refractory asthma
30 October 2012 | By GlaxoSmithKline
GlaxoSmithKline announced the start of a Phase III programme...
List view / Grid view
News
Abbott introduces Ensure Complete™ shakes for adults
30 October 2012 | By Abbott
Ensure Complete combines muscle, heart, immune system and bone benefits in one simple shake...
Drugs of abuse screening benefits from LoGiCal® reference materials
29 October 2012 | By kdm communications limited
Unilabs AB in Eskilstuna, Sweden, is taking advantage of LGC Standards’ LoGiCal reference materials...
Shionogi and ViiV Healthcare announce new agreement to commercialise and develop integrase inhibitor portfolio
29 October 2012 | By GlaxoSmithKline
ViiV Healthcare Ltd and Shionogi & Co., Ltd., have entered into an agreement...
European approval granted for Trajenta® (linagliptin) tablets
26 October 2012 | By Boehringer Ingelheim
Boehringer Ingelheim and Eli Lilly and Company today announced that the European Commission has approved an expanded therapeutic indication for the DPP-4 inhibitor Trajenta® (linagliptin) to include use in combination with insulin in adults with Type 2 Diabetes.
Melbourne scientists develop cows’ milk that protects against HIV
26 October 2012 | By F T I Consulting
Melbourne researchers have developed cows’ milk that can protect human cells from human immunodeficiency virus (HIV)...
The Respimat® success story
26 October 2012 | By Boehringer Ingelheim
Successful treatment of respiratory diseases also depends on how much of the active substance enters the patient's lung...
Daiichi Sankyo completes enrolment in Hokusai-VTE
25 October 2012 | By Daiichi Sankyo
Edoxaban is an investigational, once daily, novel oral factor Xa inhibitor...
Novartis confident in safety and efficacy of its seasonal influenza vaccines produced in Italy
25 October 2012 | By Novartis
Confidence in the safety and efficacy of seasonal influenza vaccines...
FDA discloses focus of Advisory Committee meeting on insulin degludec and insulin degludec/insulin aspart
25 October 2012 | By Novo Nordisk
“This meeting will focus on the cardiovascular safety of two products..."
The British Laboratory Managers Association to launch at LAB INNOVATIONS
24 October 2012 | By Energy PR
The British Laboratory Managers Association is being launched by GAMBICA...
Abbott’s ALK test is now available in Europe as a companion diagnostic test to aid in identifying patients for targeted lung cancer therapy
24 October 2012 | By Abbott
ALK test now available in Europe...
Pfizer’s XALKORI® receives conditional marketing authorization from the European Commission
24 October 2012 | By Pfizer
Conditional marketing authorization for XALKORI® in the EU granted...
Abbott announces data evaluating reduction of steroid usage with HUMIRA® (Adalimumab)
24 October 2012 | By Abbott
"These data suggest that adalimumab-treated patients were able to reduce steroid usage..."
Results from new Phase III study amongst women for corifollitropin alfa, an investigational fertility treatment for controlled ovarian stimulation
23 October 2012 | By Merck
New Phase III study presented...
